Art

J-GLOBAL ID：201602230173872451   Reference number：16A1164722

Intellectual property protection of protease inhibitor indinavir:statusquo and risk analysis

プロテアーゼ阻害剤剤Yinの知的所有権保護状況とリスク分析【JST・京大機械翻訳】

Author (5)： Yang Qin (Patent Examination Cooperation Center of the Patent Office, SIPO) ,  Bian Zhijia (Patent Examination Cooperation Center of the Patent Office, SIPO) ,  Hu Jingdong (Patent Examination Cooperation Center of the Patent Office, SIPO) ,  Zhang Huiyan (Patent Examination Cooperation Center of the Patent Office, SIPO) ,  Sheng Li (Institute of Health Service and Medical Information, Academy of Military Medical Sciences)
Material： Junshi Yixue
Volume： 40  Issue： 6  Page： 515-519  Publication year： 2016 
JST Material Number： C2949A  ISSN： 1674-9960  Document type： Article
Article type： 原著論文  Country of issue： China (CHN)  Language： CHINESE (ZH)

Abstract/Point： This article makes an analysis...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1164722&from=J-GLOBAL&jstjournalNo=C2949A") }}

Thesaurus term： *intellectual property ,  *risk analysis ,  time limit

Author keywords (4)： indinavir ,  protease inhibitor ,  patent analysis ,  intellectual property protection

JST classification (1)： Industrial property  (HA03000C)

Substance index (1)： Indinavir

Terms in the title (4)： プロテアーゼ阻害剤 ,  知的所有権 ,  状況 ,  リスク分析